Search

Peter W Swaan

from Gainesville, FL
Age ~59
Get Report
Also known as:
Peter Willem Swaan, Peter W Swann, Peter Swan, Pete R Swan
Connected to:
Jim Swab, 81John C Swab, 73Kathy J Swab, 62Laurel E Swab, 55Raeanne M Swab, 35Sabrina N Swab, 33Sherry B Swab, 52Wayne E Swab, 97Raymond S Swaback, 70Echo Swabb, 41

Peter Swaan Phones & Addresses

  • Gainesville, FL
  • 1111 Allison St NW, Washington, DC 20011
  • 8169 E Beach Dr NW, Washington, DC 20012
  • 417 12Th St, Washington, DC 20002
  • Laurel, MD
  • Baltimore, MD
  • Columbus, OH

Work

Company: University of maryland, baltimore Sep 2011 Position: Associate dean for research and graduate studies

Education

Degree: Postdoc School / High School: University of California, San Francisco 1994 to 1996 Specialities: Pharmaceutical Chemistry

Skills

Drug Delivery • Pharmacokinetics • In Vitro • Drug Discovery • Cell Biology • Drug Metabolism • Protein Chemistry • Pharmaceutical Research • Pharmaceutics • Pharmacology • Pharmaceutical Industry • Biochemistry • Life Sciences • Molecular Biology • Biotechnology • Lifesciences • Pharmacodynamics • Computational Chemistry • Cell Culture • Science • Drug Development • Editorial • Hplc • Biopharmaceuticals • Computational Biology • Immunology • In Vivo • Protein Purification • Animal Models • Toxicology • Oral Absorption • Drug Transport • Clinical Pharmacology • Editorial Strategy • Drug Product • Cell • Medicinal Chemistry • Technology Transfer • Chemistry • Western Blotting • Cancer • Organic Chemistry • Nanotechnology • Uv/Vis • Nmr • Chromatography • Analytical Chemistry • Lc Ms • Pharmaceuticals • High Performance Liquid Chromatography

Languages

English • Dutch • German • French

Industries

Higher Education

Resumes

Resumes

Peter Swaan Photo 1

Department Chair

View page
Location:
8169 east Beach Dr northwest #northwest, Washington, DC 20012
Industry:
Higher Education
Work:
University of Maryland, Baltimore since Sep 2011
Associate Dean for Research and Graduate Studies
University of Maryland, Baltimore since Sep 2008
Professor of Pharmaceutical Sciences
University of Maryland, Baltimore since Jan 2007
Director, UMB Center for Nanomedicine and Cellular Delivery
University of Maryland, Baltimore (UMB) Jan 2002 - Aug 2008
Associate Professor
The Ohio State University Sep 1996 - Aug 2001
Assistant Professor
Education:
University of California, San Francisco 1994 - 1996
Postdoc, Pharmaceutical Chemistry University of Utrecht 1989 - 1993
PhD, Biopharmaceutics University of Michigan 1991 - 1991
Visiting Scientist, Pharmaceutics University of Utrecht 1984 - 1989
MS, Pharmacy Leiden University 1983 - 1984
Propaedeuse, Pharmacy Hugo de Groot 1977 - 1983
Skills:
Drug Delivery
Pharmacokinetics
In Vitro
Drug Discovery
Cell Biology
Drug Metabolism
Protein Chemistry
Pharmaceutical Research
Pharmaceutics
Pharmacology
Pharmaceutical Industry
Biochemistry
Life Sciences
Molecular Biology
Biotechnology
Lifesciences
Pharmacodynamics
Computational Chemistry
Cell Culture
Science
Drug Development
Editorial
Hplc
Biopharmaceuticals
Computational Biology
Immunology
In Vivo
Protein Purification
Animal Models
Toxicology
Oral Absorption
Drug Transport
Clinical Pharmacology
Editorial Strategy
Drug Product
Cell
Medicinal Chemistry
Technology Transfer
Chemistry
Western Blotting
Cancer
Organic Chemistry
Nanotechnology
Uv/Vis
Nmr
Chromatography
Analytical Chemistry
Lc Ms
Pharmaceuticals
High Performance Liquid Chromatography
Languages:
English
Dutch
German
French

Publications

Us Patents

Novel Antioxidants And Methods Of Treatment

View page
US Patent:
20090318454, Dec 24, 2009
Filed:
Mar 24, 2009
Appl. No.:
12/410133
Inventors:
Carl P. Weiner - Mission Hills KS, US
Peter Swaan - Laurel MD, US
Jeffrey Aube - Lawrence KS, US
Abhijit Ray - Salt Lake City UT, US
International Classification:
A61K 31/53
C07C 251/60
A61K 31/195
C07D 253/065
US Classification:
514242, 562440, 562426, 514562, 514567, 544182
Abstract:
Formula 1 is an antioxidant compound, wherein R, R1, or D is an antioxidant substituent; R and D are each independently selected from hydrogen or groups containing cysteine, thiols, disulfides, amino acids, amines, amides, or carboxylic acids; when one of R or D is hydrogen, the other includes a thiol, disulfide, or carboxylic acid; A is CO, SO, SO, or C═S; E is one or more ring groups which are aromatic, carbocyclic, and/or heterocyclic 5, 6 and 7 membered rings being mono, bi, tri, tetra, penta, hexa, hepta or octa cyclic fused rings that are substituted or unsubstituted, each heterocyclic ring can include hetero atoms chosen from to O, S, N, Se, or P; each R1 is at a para, meta, and/or ortho position; n is 1, 2, 3, 4, or 5 for each ring; and each R1 is hydrogen or an antioxidant substituent.

Transdermal Delivery Of Opioid Antagonist Prodrugs

View page
US Patent:
6569449, May 27, 2003
Filed:
Nov 13, 2000
Appl. No.:
09/711640
Inventors:
Audra L. Stinchcomb - Latham NY
Peter W. Swaan - Columbus OH
Assignee:
University of Kentucky Research Foundation - Lexington KY
International Classification:
A61F 1300
US Classification:
424449, 424443, 424448
Abstract:
A composition, a method and an apparatus for transdermally delivering an effective amount of opioid antagonists derived from prodrugs for treatment of eating disorders, narcotic dependence and alcoholism. In addition, the present invention relates to a composition, a method and an apparatus for transdermally delivering an effective amount of an opioid and opioid antagonist derived from an opioid agonist and one of an opioid antagonist and a prodrug for treatment of pain.
Control profile
Peter W Swaan from Gainesville, FL, age ~59 Get Report